Hans Clevers

Director/Board Member at

F. Hoffmann-La Roche Ltd.

69 year

80 connections

Health Technology

Commercial Services

Finance

Profile

Hans Clevers is the founder of Surrozen Operating, Inc. (2015) and Xilis, Inc. (2019).
Current jobs include Director at F.
Hoffmann-La Roche Ltd. (2019) and Professor-Molecular Genetics at the University of Utrecht (2002).
Former jobs include Director at Genentech, Inc., Director at the American Association for Cancer Research (2012-2015), Director-Royal Netherlands Academy at Hubrecht Institute (2002-2012), Research Director at Princess Maxima Centre For Pediatric Oncology (2015-2019), Venture Partner at EQT Life Sciences Group BV (2001-2022), President at The Royal Netherlands Academy of Arts & Sciences (2012-2015), President at The International Society for Stem Cell Research (2017-2018), President at International Society of Differentiation, Inc. (2006-2008), Chief Scientific Officer at Hubrecht Organoid Technology Foundation (2014-2020), and Head-Pharma Research & Early Development at Roche Holding AG (2022-2025).
Education includes graduate (1982) and doctorate (1985) degrees from the University of Utrecht.

Hans Clevers active positions

Companies	Position	Start
F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Director/Board Member	05/03/2019
University of Utrecht University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01/01/1989

All active positions of Hans Clevers

Former positions of Hans Clevers

Companies	Position	End
ROCHE HOLDING AG	Director/Board Member	18/03/2022
LSP Management Group BV LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million.	Investment Committee Member	28/02/2022
Hubrecht Organoid Technology Foundation	Corporate Officer/Principal	01/01/2020
Princess Maxima Centre For Pediatric Oncology	Chief Tech/Sci/R&D Officer	01/01/2019
The International Society for Stem Cell Research The International Society for Stem Cell Research The International Society for Stem Cell Research (ISSCR) is a nonprofit organization dedicated to advancing stem cell science and its applications to human health. The non-profit company is based in Deerfield, IL. It represents nearly 5,000 members from over 80 countries, including scientists, educators, ethicists, clinicians, and business leaders. ISSCR promotes rigorous and ethical research through the development of international guidelines and quality standards, and provides resources such as the open-access journal Stem Cell Reports, standards documents for human stem cell use, and educational programs including annual meetings, symposia, webinars, and on-demand scientific content. The society supports workforce development by engaging early career scientists and trainees, fosters collaboration through a directory of stem cell societies and institutes, and conducts advocacy and policy efforts to provide scientific input to regulatory agencies and combat unproven stem cell therapies. ISSCR emphasizes equity, diversity, and inclusion, and offers resources for researchers, clinicians, educators, patients, and policymakers. The organization facilitates access to funding opportunities, supports continuing education, and promotes public and patient education. Membership benefits include networking, reduced fees for meetings and publishing, and access to scientific content.	President	01/01/2018

See the detail of Hans Clevers's experience

Training of Hans Clevers

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hans Clevers's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Health Technology
Roche Holding AG Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics	Health Technology
F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
LSP Management Group BV LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million.	Finance
University of Utrecht University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
American Association for Cancer Research American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer	Commercial Services
The Royal Netherlands Academy of Arts & Sciences The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Provides research services in the field on science and art	Commercial Services
The International Society for Stem Cell Research The International Society for Stem Cell Research The International Society for Stem Cell Research (ISSCR) is a nonprofit organization dedicated to advancing stem cell science and its applications to human health. The non-profit company is based in Deerfield, IL. It represents nearly 5,000 members from over 80 countries, including scientists, educators, ethicists, clinicians, and business leaders. ISSCR promotes rigorous and ethical research through the development of international guidelines and quality standards, and provides resources such as the open-access journal Stem Cell Reports, standards documents for human stem cell use, and educational programs including annual meetings, symposia, webinars, and on-demand scientific content. The society supports workforce development by engaging early career scientists and trainees, fosters collaboration through a directory of stem cell societies and institutes, and conducts advocacy and policy efforts to provide scientific input to regulatory agencies and combat unproven stem cell therapies. ISSCR emphasizes equity, diversity, and inclusion, and offers resources for researchers, clinicians, educators, patients, and policymakers. The organization facilitates access to funding opportunities, supports continuing education, and promotes public and patient education. Membership benefits include networking, reduced fees for meetings and publishing, and access to scientific content.
Hubrecht Institute Hubrecht Institute BiotechnologyHealth Technology Develops biology and stem cells	Health Technology
International Society of Differentiation, Inc. International Society of Differentiation, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and communication in fields of cell and molecular biology & oncology	Commercial Services
Surrozen Operating, Inc. Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines	Health Technology
Princess Maxima Centre For Pediatric Oncology
Hubrecht Organoid Technology Foundation
Xilis, Inc. Xilis, Inc. Medical SpecialtiesHealth Technology Develops droplet-based microfluidics technology devices for precision cancer diagnostics and drug development	Health Technology